Home/Phlox Therapeutics/Prof. dr. Eva Van Rooij
PD

Prof. dr. Eva Van Rooij

Founder and CSO

Phlox Therapeutics

Phlox Therapeutics Pipeline

DrugIndicationPhase
RNA Therapy for Genetic LaminopathiesCardiomyopathy due to LMNA mutationsPreclinical